gastrointestinal neoplasms
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who will be eligible for insurance coverage of endoscopic submucosal dissection between March 1 and December 31, 2022, and who have been fully informed about their participation in the study, and who have given their free and voluntary consent to be treated with the new device based on their full understanding of the study.
Exclusion criteria
Exclusion criteria: Exclusion criteria include suspected disseminated intravascular coagulation syndrome, severe heart failure, active thromboembolism at the time of study entry, severe respiratory failure, pregnancy or women of childbearing potential, and other subjects deemed unsuitable by the study investigator (subinvestigator).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to apply new instruments and completion rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment time, batch resection rate, amount of local fluid used, and frequency of incidentalities (treatment-related bleeding, post-treatment hemorrhage, perforation) | — |
Countries
Japan
Contacts
Nagasaki Harbor Medical Center gastroenterology